Insider · CIK 0001973838
Melanie Gloria
Files at IMVT (Immunovant, Inc.). First filing Nov 21, 2025, latest Oct 9, 2026.
Melanie Gloria files SEC Form 4 as COO at IMVT (Immunovant, Inc.). Since Nov 21, 2025, Melanie Gloria has reported 0 open-market buys worth $0 and 3 open-market sells worth $460k, the latest filed on Oct 9, 2026.
A track record needs three past buys with six months of prices behind them; Melanie Gloria has 0, so none is measured yet.
The newest scored trade: sold $72k of IMVT on Oct 7, 2026, filed Oct 9, 2026, scored 43 (moderate). In the last 12 months: 0 buys worth $0 and 3 sells worth $460k.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
IMVT: Immunovant, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 43Moderate | Immunovant, Inc. | $72k 2,241 shares | -1% | +99% from low-29% from high | |
| 29Weak | IMVTsell Immunovant, Inc. | $90k 3,238 shares | -2% | +105% from low-1% from high | |
| 49Moderate | Immunovant, Inc. | $298k 12,626 shares | -7% | +71% from low-21% from high |
Transactions
Every row this insider has filed, 10 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 7, 2026 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,241 | $32.06 | $72k | 217,060 | 4 d ago |
| Feb 25, 2026 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -1,437 | $26.98 | $39k | 172,074 | Feb 27, 2026 |
| Feb 25, 2026 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -859 | $28.16 | $24k | 171,215 | Feb 27, 2026 |
| Feb 25, 2026 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -942 | $28.90 | $27k | 170,273 | Feb 27, 2026 |
| Nov 20, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -10,251 | $23.54 | $241k | 175,886 | Nov 21, 2025 |
| Nov 20, 2025 | IMVT Immunovant, Inc. | SOpen-market sale Common Stock | -2,375 | $23.97 | $57k | 173,511 | Nov 21, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Common Stock | +76,181 | $0.00 | $0 | 186,137 | Apr 3, 2025 |
| Apr 1, 2025 | IMVT Immunovant, Inc. | AGrant or award Stock Option (right to buy)derivative | +107,297 | $0.00 | $0 | 107,297 | Apr 3, 2025 |
| Nov 18, 2024 | IMVT Immunovant, Inc. | AGrant or award Common Stock | +109,956 | $0.00 | $0 | 109,956 | Nov 20, 2024 |
| Nov 18, 2024 | IMVT Immunovant, Inc. | AGrant or award Stock Option (right to buy)derivative | +137,446 | $0.00 | $0 | 137,446 | Nov 20, 2024 |
Questions about Melanie Gloria
Answered from the filings on this page, as of the latest one.
Is Melanie Gloria buying or selling?
In the last 12 months Melanie Gloria reported 0 open-market buys worth $0 and 3 open-market sells worth $460k on SEC Form 4; the latest was sold $72k of IMVT on Oct 7, 2026. Grants, option exercises and tax withholding are not counted.
How did Melanie Gloria's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Melanie Gloria has 0.
Where does Melanie Gloria file Form 4?
Melanie Gloria has filed Form 4 at IMVT (Immunovant, Inc.) as Chief Operating Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.